6568 — KNC Laboratories Co Balance Sheet
0.000.00%
- ¥8bn
- ¥8bn
- ¥9bn
- 64
- 87
- 55
- 81
Annual balance sheet for KNC Laboratories Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,476 | 1,963 | 1,974 | 2,297 | 3,312 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,527 | 1,142 | 2,518 | 2,791 | 2,626 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,335 | 5,137 | 6,347 | 7,459 | 8,559 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,696 | 6,961 | 6,909 | 7,200 | 8,475 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 12,771 | 12,781 | 13,952 | 15,405 | 18,622 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,716 | 1,287 | 2,047 | 2,728 | 2,969 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,944 | 2,660 | 3,377 | 3,659 | 5,535 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 9,827 | 10,121 | 10,575 | 11,745 | 13,087 |
Total Liabilities & Shareholders' Equity | 12,771 | 12,781 | 13,952 | 15,405 | 18,622 |
Total Common Shares Outstanding |